Talcum Powder Cancer Lawsuit

Courtroom View News Allows The Public To Hear Both Sides Of A Talcum Powder Ovarian Cancer Allegation

Transparency may focus attention on the science behind talc cancer allegations

Thursday, February 29, 2024 - All eyes are on a Miami Florida courtroom as a talcum powder ovarian cancer trial is underway pitting plaintiff Bob Sugarman against health care conglomerate Johnson & Johnson. Sugarman alleges that using Johnson's Baby Powder, regularly and for a long time caused the death of his wife, the late Marilyn Seskin at age 69 after a three-year bout with cancer. Ms. Seskin died several years ago from a rare form of ovarian cancer called peritoneal cancer. The lawsuit alleges that Seskin used Johnson's baby powder for her entire life as a method of feminine hygiene as the company recommended women to do in between showers. The iconic brand Shower to Shower implied just such usage. Despite the allegations, Courtroom View News (CVN) which is covering the trial live on the internet, told the jury in opening arguments that their talc-based products are safe, pure, and asbestos-free.

An additional wrinkle in the case is the defense intention to argue that Seskin's occupation as a radiologist caused occupational-related exposure to radiation and was the root cause of her disease. As the talcum powder lawsuit unfolds, it is expected that expert testimonies and evidence presentations will delve into the lack of scientific research surrounding talc and its potential health hazards, particularly concerning ovarian cancer. CVN reported the defense citing the lack of substantial scientific studies that link talc usage to peritoneal cancer. " Defense attorney Allison Brown of Skadden, representing J&J, insisted the company's talc products have always been safe and were extensively tested to screen for asbestos. She suggested primary peritoneal cancer would be far more widespread if it had any link to talc powder use and noted Seskin had many of the risk factors associated with the rare illness."There is not a single epidemiology study that concludes cosmetic talc causes ovarian cancer or primary peritoneal cancer," Brown told the jury."

Webcasting and comprehensive recording of the trial ensure transparency and accessibility, enabling the public to observe the legal proceedings firsthand. Johnson & Johnson claims that juries in the past, including one Missouri jury that awarded 22 women $4.89 billion, have been incensed by Johnson & Johnson's inexcusable corporate behavior and awarded the inflated figure. The company hopes that broadcasting the proceeding live on the internet may help focus the public's and the jury's attention on the scientific facts and not get carried away with a guilty verdict based on hyperbole. In addition, this legal action underscores the increasing scrutiny surrounding the safety of cosmetic talc products and the responsibility of manufacturers to safeguard consumer health. Beyond the immediate legal implications, the outcome of this trial may have far-reaching effects on the regulations governing talc usage and may prompt companies to reassess their product formulations and safety measures. Most cosmetics companies whose makeup or other products are based on talc have reformulated their products around cornstarch over the adverse publicity and resultant lack of demand for talc products.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.